Cart
sales@molnova.com
NEO 376
CAS No. 496921-73-4
NEO 376( SPI-376 )
Catalog No. M26328 CAS No. 496921-73-4
NEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 150 | In Stock |
|
| 5MG | 136 | In Stock |
|
| 10MG | 216 | In Stock |
|
| 25MG | 372 | In Stock |
|
| 50MG | 512 | In Stock |
|
| 100MG | 686 | In Stock |
|
| 200MG | 923 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNEO 376
-
NoteResearch use only, not for human use.
-
Brief DescriptionNEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.
-
DescriptionNEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.
-
In Vitro——
-
In Vivo——
-
SynonymsSPI-376
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorAlkyl/ether| PEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number496921-73-4
-
Formula Weight357.88
-
Molecular FormulaC20H24ClN3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (349.28 mM)
-
SMILESClc1cccc(c1)N1CCN(CCn2ccc3c2CCCC3=O)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
-
Bromocriptine mesyla...
Bromocriptine (CB-154) is a dopamine D2 receptor agonist (Ki=3 nM) and and various serotonin receptors, also inhibits the release of glutamate by reversing the glutamate GLT1 transporter.
-
OS-3-106
OS-3-106 ?is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.
-
Pericyazine
Pericyazine is a selective D2-dopamine receptor antagonist. Pericyazine is a first-generation antipsychotic drug that is used as an adjunct to the short-term management of severe anxiety states and psychosis.
